Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A partially demineralized dentin block is an autologous bone graft substitute prepared from a patient's own extracted teeth. The process involves cleaning and grinding the tooth (primarily the dentin) and then subjecting it to partial demineralization, often using a specialized device like the Tooth Transformer. This processing exposes the organic matrix, including Type I collagen and endogenous growth factors such as bone morphogenetic proteins (BMPs), which are otherwise sequestered in the mineralized tissue. In clinical applications for alveolar ridge preservation, the processed dentin is typically mixed with leukocyte- and platelet-rich fibrin (L-PRF) to form a cohesive "block" or mass. This material provides an osteoconductive scaffold and osteoinductive signals to promote new bone formation and maintain hard tissue volume in extraction sockets prior to dental implant placement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on partially demineralized dentin block (Cairo University).